Kvelux (Quetiapine)

Quetiapine blocks several neurotransmitter receptors, chiefly serotonin 5‑HT2A and dopamine D2, while also antagonising histamine H1, adrenergic α1 and other receptors. This broad antagonism balances dopaminergic and serotonergic activity, reducing psychotic symptoms, stabilising mood, and supporting antidepressant effects.

The appropriate dose of Kvelux is individualized by the prescribing clinician based on the specific indication, severity of symptoms, patient age, metabolic status and any concomitant medications. No fixed regimen can be provided without a qualified healthcare professional’s assessment.

Safety data for quetiapine in pregnancy and lactation are limited. The product is classified as having an unknown pregnancy category, and clinicians should weigh potential benefits against risks. Women who are pregnant, planning pregnancy, or breastfeeding should discuss use with their healthcare provider.

To request Kvelux, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Both quetiapine (Kvelux) and risperidone belong to the atypical antipsychotic class, but they differ in receptor affinity and side‑effect profiles. Quetiapine has stronger antihistaminic activity, often causing more sedation, while risperidone tends to have higher prolactin‑raising potential. Choice depends on individual patient response, tolerability and clinical judgment.

Kvelux should be stored at room temperature, preferably below 25 °C, in its original packaging to protect it from moisture and light. Do not store in humid environments such as bathrooms, and keep out of reach of children.

Kvelux is taken orally, usually as a tablet, with or without food as directed by the prescriber. The tablet should be swallowed whole with water and not crushed or chewed unless specifically instructed by a healthcare professional.

Serious risks include neuroleptic malignant syndrome, a potentially life‑threatening reaction characterized by fever, muscle rigidity and autonomic instability, as well as agranulocytosis, severe orthostatic hypotension, and increased suicidal thoughts in younger adults. Immediate medical attention is required if any of these occur.

Kvelux is contraindicated in patients with known hypersensitivity to quetiapine or any of its excipients. Caution is also advised for individuals with uncontrolled cardiovascular disease, severe hepatic impairment, or a history of neuroleptic malignant syndrome. The medication should not be used without medical supervision.